nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR7—Parkinson's disease	0.324	0.441	CbGaD
Methysergide—HTR1A—Parkinson's disease	0.248	0.338	CbGaD
Methysergide—HTR2A—Parkinson's disease	0.163	0.222	CbGaD
Methysergide—HTR7—enteric nervous system—Parkinson's disease	0.00693	0.0596	CbGeAlD
Methysergide—HTR7—superior cervical ganglion—Parkinson's disease	0.00663	0.057	CbGeAlD
Methysergide—HTR7—myenteric nerve plexus—Parkinson's disease	0.00525	0.0452	CbGeAlD
Methysergide—HTR7—locus ceruleus—Parkinson's disease	0.00458	0.0393	CbGeAlD
Methysergide—HTR2A—enteric nervous system—Parkinson's disease	0.00432	0.0372	CbGeAlD
Methysergide—HTR7—sympathetic nervous system—Parkinson's disease	0.00362	0.0311	CbGeAlD
Methysergide—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00328	0.0282	CbGeAlD
Methysergide—HTR2A—locus ceruleus—Parkinson's disease	0.00285	0.0245	CbGeAlD
Methysergide—HTR1B—telencephalic ventricle—Parkinson's disease	0.00281	0.0242	CbGeAlD
Methysergide—HTR1D—telencephalic ventricle—Parkinson's disease	0.00272	0.0234	CbGeAlD
Methysergide—HTR2C—telencephalic ventricle—Parkinson's disease	0.0027	0.0232	CbGeAlD
Methysergide—HTR7—pons—Parkinson's disease	0.00264	0.0227	CbGeAlD
Methysergide—HTR7—autonomic nervous system—Parkinson's disease	0.00243	0.0209	CbGeAlD
Methysergide—HTR2A—cerebellar cortex—Parkinson's disease	0.00233	0.02	CbGeAlD
Methysergide—HTR1A—telencephalic ventricle—Parkinson's disease	0.00227	0.0195	CbGeAlD
Methysergide—HTR2A—sympathetic nervous system—Parkinson's disease	0.00226	0.0194	CbGeAlD
Methysergide—HTR7—telencephalic ventricle—Parkinson's disease	0.00217	0.0187	CbGeAlD
Methysergide—HTR1F—forebrain—Parkinson's disease	0.00179	0.0154	CbGeAlD
Methysergide—HTR7—peripheral nervous system—Parkinson's disease	0.00175	0.0151	CbGeAlD
Methysergide—HTR2A—pons—Parkinson's disease	0.00164	0.0141	CbGeAlD
Methysergide—HTR1E—brainstem—Parkinson's disease	0.00161	0.0138	CbGeAlD
Methysergide—HTR1E—forebrain—Parkinson's disease	0.00155	0.0134	CbGeAlD
Methysergide—HTR2A—autonomic nervous system—Parkinson's disease	0.00152	0.013	CbGeAlD
Methysergide—HTR7—nerve—Parkinson's disease	0.00137	0.0118	CbGeAlD
Methysergide—HTR2A—telencephalic ventricle—Parkinson's disease	0.00135	0.0116	CbGeAlD
Methysergide—HTR6—forebrain—Parkinson's disease	0.00122	0.0105	CbGeAlD
Methysergide—HTR2A—peripheral nervous system—Parkinson's disease	0.00109	0.00941	CbGeAlD
Methysergide—Nicergoline—CYP2D6—Parkinson's disease	0.00108	0.144	CrCbGaD
Methysergide—HTR1A—hindbrain—Parkinson's disease	0.00107	0.00922	CbGeAlD
Methysergide—HTR1F—head—Parkinson's disease	0.00103	0.00883	CbGeAlD
Methysergide—HTR7—hindbrain—Parkinson's disease	0.00102	0.00881	CbGeAlD
Methysergide—HTR1F—nervous system—Parkinson's disease	0.000974	0.00837	CbGeAlD
Methysergide—HTR1F—central nervous system—Parkinson's disease	0.000938	0.00806	CbGeAlD
Methysergide—HTR1E—head—Parkinson's disease	0.00089	0.00765	CbGeAlD
Methysergide—HTR2A—nerve—Parkinson's disease	0.000853	0.00733	CbGeAlD
Methysergide—HTR1E—nervous system—Parkinson's disease	0.000844	0.00725	CbGeAlD
Methysergide—HTR1E—central nervous system—Parkinson's disease	0.000812	0.00698	CbGeAlD
Methysergide—HTR1B—brainstem—Parkinson's disease	0.000762	0.00655	CbGeAlD
Methysergide—HTR1F—brain—Parkinson's disease	0.000744	0.0064	CbGeAlD
Methysergide—HTR1D—brainstem—Parkinson's disease	0.000737	0.00634	CbGeAlD
Methysergide—HTR1B—forebrain—Parkinson's disease	0.000735	0.00632	CbGeAlD
Methysergide—HTR2C—brainstem—Parkinson's disease	0.00073	0.00628	CbGeAlD
Methysergide—HTR1D—forebrain—Parkinson's disease	0.000712	0.00612	CbGeAlD
Methysergide—HTR2C—forebrain—Parkinson's disease	0.000705	0.00606	CbGeAlD
Methysergide—HTR6—head—Parkinson's disease	0.000698	0.006	CbGeAlD
Methysergide—HTR6—nervous system—Parkinson's disease	0.000662	0.00569	CbGeAlD
Methysergide—HTR2B—forebrain—Parkinson's disease	0.000662	0.00569	CbGeAlD
Methysergide—HTR1E—brain—Parkinson's disease	0.000645	0.00554	CbGeAlD
Methysergide—Methylergometrine—DRD1—Parkinson's disease	0.000644	0.0853	CrCbGaD
Methysergide—HTR2A—hindbrain—Parkinson's disease	0.000639	0.00549	CbGeAlD
Methysergide—HTR6—central nervous system—Parkinson's disease	0.000637	0.00548	CbGeAlD
Methysergide—HTR1B—cardiovascular system—Parkinson's disease	0.000621	0.00534	CbGeAlD
Methysergide—HTR1A—brainstem—Parkinson's disease	0.000615	0.00528	CbGeAlD
Methysergide—HTR1D—cardiovascular system—Parkinson's disease	0.000602	0.00517	CbGeAlD
Methysergide—HTR1A—forebrain—Parkinson's disease	0.000593	0.0051	CbGeAlD
Methysergide—HTR7—brainstem—Parkinson's disease	0.000587	0.00505	CbGeAlD
Methysergide—HTR7—forebrain—Parkinson's disease	0.000567	0.00487	CbGeAlD
Methysergide—HTR2B—cardiovascular system—Parkinson's disease	0.00056	0.00481	CbGeAlD
Methysergide—HTR2C—medulla oblongata—Parkinson's disease	0.000509	0.00438	CbGeAlD
Methysergide—HTR6—brain—Parkinson's disease	0.000506	0.00435	CbGeAlD
Methysergide—HTR1A—cardiovascular system—Parkinson's disease	0.000501	0.00431	CbGeAlD
Methysergide—HTR1B—midbrain—Parkinson's disease	0.000485	0.00417	CbGeAlD
Methysergide—SIGMAR1—medulla oblongata—Parkinson's disease	0.000479	0.00412	CbGeAlD
Methysergide—HTR7—cardiovascular system—Parkinson's disease	0.000479	0.00412	CbGeAlD
Methysergide—HTR1B—spinal cord—Parkinson's disease	0.000473	0.00407	CbGeAlD
Methysergide—HTR1D—midbrain—Parkinson's disease	0.00047	0.00404	CbGeAlD
Methysergide—HTR2C—midbrain—Parkinson's disease	0.000465	0.004	CbGeAlD
Methysergide—HTR2C—spinal cord—Parkinson's disease	0.000454	0.0039	CbGeAlD
Methysergide—Lisuride—DRD3—Parkinson's disease	0.00044	0.0583	CrCbGaD
Methysergide—SIGMAR1—midbrain—Parkinson's disease	0.000438	0.00377	CbGeAlD
Methysergide—Bromocriptine—HTR7—Parkinson's disease	0.000433	0.0574	CrCbGaD
Methysergide—Lisuride—DRD1—Parkinson's disease	0.000432	0.0572	CrCbGaD
Methysergide—SIGMAR1—spinal cord—Parkinson's disease	0.000427	0.00367	CbGeAlD
Methysergide—HTR1B—head—Parkinson's disease	0.000421	0.00362	CbGeAlD
Methysergide—HTR7—medulla oblongata—Parkinson's disease	0.00041	0.00352	CbGeAlD
Methysergide—Bromocriptine—DRD3—Parkinson's disease	0.000407	0.054	CrCbGaD
Methysergide—HTR1D—head—Parkinson's disease	0.000407	0.0035	CbGeAlD
Methysergide—HTR2C—head—Parkinson's disease	0.000403	0.00347	CbGeAlD
Methysergide—Bromocriptine—DRD1—Parkinson's disease	0.0004	0.053	CrCbGaD
Methysergide—HTR2A—embryo—Parkinson's disease	0.0004	0.00344	CbGeAlD
Methysergide—HTR1B—nervous system—Parkinson's disease	0.000399	0.00343	CbGeAlD
Methysergide—HTR1A—midbrain—Parkinson's disease	0.000392	0.00337	CbGeAlD
Methysergide—HTR1D—nervous system—Parkinson's disease	0.000386	0.00332	CbGeAlD
Methysergide—HTR1B—central nervous system—Parkinson's disease	0.000384	0.0033	CbGeAlD
Methysergide—HTR2C—nervous system—Parkinson's disease	0.000383	0.00329	CbGeAlD
Methysergide—HTR1A—spinal cord—Parkinson's disease	0.000382	0.00328	CbGeAlD
Methysergide—HTR2B—head—Parkinson's disease	0.000379	0.00326	CbGeAlD
Methysergide—HTR7—midbrain—Parkinson's disease	0.000374	0.00322	CbGeAlD
Methysergide—HTR1D—central nervous system—Parkinson's disease	0.000372	0.0032	CbGeAlD
Methysergide—HTR2C—central nervous system—Parkinson's disease	0.000368	0.00317	CbGeAlD
Methysergide—HTR2A—brainstem—Parkinson's disease	0.000366	0.00315	CbGeAlD
Methysergide—HTR7—spinal cord—Parkinson's disease	0.000365	0.00314	CbGeAlD
Methysergide—HTR2B—nervous system—Parkinson's disease	0.000359	0.00309	CbGeAlD
Methysergide—Lisuride—HTR1A—Parkinson's disease	0.000359	0.0475	CrCbGaD
Methysergide—HTR2A—forebrain—Parkinson's disease	0.000353	0.00304	CbGeAlD
Methysergide—Methylergometrine—HTR2A—Parkinson's disease	0.000351	0.0464	CrCbGaD
Methysergide—HTR2B—central nervous system—Parkinson's disease	0.000346	0.00297	CbGeAlD
Methysergide—Ergotamine—HTR1A—Parkinson's disease	0.000344	0.0456	CrCbGaD
Methysergide—HTR1A—head—Parkinson's disease	0.00034	0.00292	CbGeAlD
Methysergide—SIGMAR1—cerebellum—Parkinson's disease	0.000339	0.00291	CbGeAlD
Methysergide—Bromocriptine—HTR1A—Parkinson's disease	0.000332	0.044	CrCbGaD
Methysergide—HTR7—head—Parkinson's disease	0.000325	0.00279	CbGeAlD
Methysergide—HTR1A—nervous system—Parkinson's disease	0.000322	0.00277	CbGeAlD
Methysergide—HTR1A—central nervous system—Parkinson's disease	0.00031	0.00266	CbGeAlD
Methysergide—HTR7—nervous system—Parkinson's disease	0.000308	0.00264	CbGeAlD
Methysergide—HTR1B—brain—Parkinson's disease	0.000305	0.00262	CbGeAlD
Methysergide—Lisuride—DRD2—Parkinson's disease	0.000304	0.0403	CrCbGaD
Methysergide—HTR1A—cerebellum—Parkinson's disease	0.000303	0.0026	CbGeAlD
Methysergide—HTR2A—cardiovascular system—Parkinson's disease	0.000299	0.00257	CbGeAlD
Methysergide—HTR7—central nervous system—Parkinson's disease	0.000296	0.00255	CbGeAlD
Methysergide—HTR1D—brain—Parkinson's disease	0.000295	0.00254	CbGeAlD
Methysergide—Ergotamine—DRD2—Parkinson's disease	0.000292	0.0387	CrCbGaD
Methysergide—HTR2C—brain—Parkinson's disease	0.000292	0.00251	CbGeAlD
Methysergide—HTR7—cerebellum—Parkinson's disease	0.00029	0.00249	CbGeAlD
Methysergide—Bromocriptine—DRD2—Parkinson's disease	0.000282	0.0373	CrCbGaD
Methysergide—SIGMAR1—brain—Parkinson's disease	0.000275	0.00237	CbGeAlD
Methysergide—HTR2B—brain—Parkinson's disease	0.000275	0.00236	CbGeAlD
Methysergide—Ergonovine—ABCB1—Parkinson's disease	0.000262	0.0347	CrCbGaD
Methysergide—HTR2A—medulla oblongata—Parkinson's disease	0.000255	0.0022	CbGeAlD
Methysergide—HTR1A—brain—Parkinson's disease	0.000246	0.00212	CbGeAlD
Methysergide—Lisuride—HTR2A—Parkinson's disease	0.000235	0.0312	CrCbGaD
Methysergide—HTR7—brain—Parkinson's disease	0.000235	0.00202	CbGeAlD
Methysergide—HTR2A—midbrain—Parkinson's disease	0.000233	0.00201	CbGeAlD
Methysergide—HTR2A—spinal cord—Parkinson's disease	0.000228	0.00196	CbGeAlD
Methysergide—Ergotamine—HTR2A—Parkinson's disease	0.000226	0.0299	CrCbGaD
Methysergide—Bromocriptine—HTR2A—Parkinson's disease	0.000218	0.0289	CrCbGaD
Methysergide—Lisuride—CYP2D6—Parkinson's disease	0.000215	0.0285	CrCbGaD
Methysergide—HTR2A—head—Parkinson's disease	0.000202	0.00174	CbGeAlD
Methysergide—HTR2A—nervous system—Parkinson's disease	0.000192	0.00165	CbGeAlD
Methysergide—HTR2A—central nervous system—Parkinson's disease	0.000185	0.00159	CbGeAlD
Methysergide—HTR2A—cerebellum—Parkinson's disease	0.000181	0.00155	CbGeAlD
Methysergide—Ergotamine—ABCB1—Parkinson's disease	0.000148	0.0195	CrCbGaD
Methysergide—HTR2A—brain—Parkinson's disease	0.000147	0.00126	CbGeAlD
Methysergide—Bromocriptine—ABCB1—Parkinson's disease	0.000142	0.0188	CrCbGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD1—Parkinson's disease	2.23e-05	0.000157	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ADORA2A—Parkinson's disease	2.23e-05	0.000157	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.23e-05	0.000157	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—EDN1—Parkinson's disease	2.22e-05	0.000156	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—EDN1—Parkinson's disease	2.22e-05	0.000156	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ADORA2A—Parkinson's disease	2.21e-05	0.000156	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—EDN1—Parkinson's disease	2.2e-05	0.000155	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ADORA2A—Parkinson's disease	2.17e-05	0.000153	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD3—Parkinson's disease	2.16e-05	0.000152	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—EDN1—Parkinson's disease	2.16e-05	0.000152	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—HTR2A—Parkinson's disease	2.14e-05	0.00015	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—HTR2A—Parkinson's disease	2.13e-05	0.00015	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IGF2—Parkinson's disease	2.13e-05	0.00015	CbGpPWpGaD
Methysergide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.12e-05	0.00015	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—HTR2A—Parkinson's disease	2.12e-05	0.000149	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—ADRBK1—Parkinson's disease	2.12e-05	0.000149	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—ADRBK1—Parkinson's disease	2.11e-05	0.000148	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FGF20—Parkinson's disease	2.1e-05	0.000148	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—HTR1A—Parkinson's disease	2.09e-05	0.000147	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PDYN—Parkinson's disease	2.09e-05	0.000147	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GRM4—Parkinson's disease	2.08e-05	0.000146	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PDYN—Parkinson's disease	2.08e-05	0.000146	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—HTR2A—Parkinson's disease	2.08e-05	0.000146	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—TAC1—Parkinson's disease	2.06e-05	0.000145	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—INSR—Parkinson's disease	2.06e-05	0.000145	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IGF1R—Parkinson's disease	2.06e-05	0.000145	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—INSR—Parkinson's disease	2.06e-05	0.000145	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HTR7—Parkinson's disease	2.05e-05	0.000144	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—DRD2—Parkinson's disease	2.05e-05	0.000144	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—INSR—Parkinson's disease	2.04e-05	0.000144	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—DRD2—Parkinson's disease	2.04e-05	0.000144	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HTR7—Parkinson's disease	2.04e-05	0.000144	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ADORA2A—Parkinson's disease	2.04e-05	0.000143	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EDN1—Parkinson's disease	2.03e-05	0.000143	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—EDN1—Parkinson's disease	2.02e-05	0.000143	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD1—Parkinson's disease	2.02e-05	0.000142	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	2.01e-05	0.000142	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IGF2—Parkinson's disease	2.01e-05	0.000141	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—INSR—Parkinson's disease	2e-05	0.000141	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PENK—Parkinson's disease	1.97e-05	0.000139	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MAG—Parkinson's disease	1.97e-05	0.000139	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GFAP—Parkinson's disease	1.96e-05	0.000138	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	1.96e-05	0.000138	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GFAP—Parkinson's disease	1.95e-05	0.000137	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	1.95e-05	0.000137	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	1.95e-05	0.000137	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—HTR2A—Parkinson's disease	1.95e-05	0.000137	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—FGB—Parkinson's disease	1.94e-05	0.000137	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—FGB—Parkinson's disease	1.94e-05	0.000137	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—GRM5—Parkinson's disease	1.94e-05	0.000137	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IGF1R—Parkinson's disease	1.94e-05	0.000137	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—HTR2A—Parkinson's disease	1.94e-05	0.000137	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—HTR2A—Parkinson's disease	1.94e-05	0.000136	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR1A—Parkinson's disease	1.93e-05	0.000136	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HTR1A—Parkinson's disease	1.93e-05	0.000136	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—GRM5—Parkinson's disease	1.93e-05	0.000136	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—FGB—Parkinson's disease	1.93e-05	0.000136	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—HTR2A—Parkinson's disease	1.93e-05	0.000136	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	1.92e-05	0.000135	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR1A—Parkinson's disease	1.92e-05	0.000135	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EDN1—Parkinson's disease	1.92e-05	0.000135	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TAC1—Parkinson's disease	1.91e-05	0.000134	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TAC1—Parkinson's disease	1.9e-05	0.000134	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TAC1—Parkinson's disease	1.89e-05	0.000133	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—FGB—Parkinson's disease	1.89e-05	0.000133	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—HTR2A—Parkinson's disease	1.89e-05	0.000133	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HTR1A—Parkinson's disease	1.88e-05	0.000132	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—INSR—Parkinson's disease	1.88e-05	0.000132	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD1—Parkinson's disease	1.87e-05	0.000132	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—NGF—Parkinson's disease	1.87e-05	0.000132	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD1—Parkinson's disease	1.87e-05	0.000131	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD1—Parkinson's disease	1.85e-05	0.000131	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TAC1—Parkinson's disease	1.85e-05	0.00013	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	1.83e-05	0.000129	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD1—Parkinson's disease	1.82e-05	0.000128	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD3—Parkinson's disease	1.81e-05	0.000127	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—EDN1—Parkinson's disease	1.81e-05	0.000127	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD3—Parkinson's disease	1.81e-05	0.000127	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	1.8e-05	0.000127	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—EDN1—Parkinson's disease	1.8e-05	0.000127	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD3—Parkinson's disease	1.8e-05	0.000126	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HTR2A—Parkinson's disease	1.78e-05	0.000125	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—FGB—Parkinson's disease	1.78e-05	0.000125	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	1.77e-05	0.000125	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	1.77e-05	0.000125	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—HTR2A—Parkinson's disease	1.77e-05	0.000125	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR1A—Parkinson's disease	1.77e-05	0.000124	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—NGF—Parkinson's disease	1.76e-05	0.000124	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD3—Parkinson's disease	1.76e-05	0.000124	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TAC1—Parkinson's disease	1.74e-05	0.000122	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.71e-05	0.000121	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD1—Parkinson's disease	1.71e-05	0.00012	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FGF20—Parkinson's disease	1.7e-05	0.00012	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	1.7e-05	0.000119	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FGF20—Parkinson's disease	1.69e-05	0.000119	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ADRBK1—Parkinson's disease	1.69e-05	0.000119	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ADRBK1—Parkinson's disease	1.69e-05	0.000119	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HTR2A—Parkinson's disease	1.68e-05	0.000118	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ADRBK1—Parkinson's disease	1.68e-05	0.000118	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	1.68e-05	0.000118	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—APOE—Parkinson's disease	1.65e-05	0.000116	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD3—Parkinson's disease	1.65e-05	0.000116	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADORA2A—Parkinson's disease	1.65e-05	0.000116	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADORA2A—Parkinson's disease	1.64e-05	0.000116	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ADRBK1—Parkinson's disease	1.64e-05	0.000116	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—EDN1—Parkinson's disease	1.64e-05	0.000116	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—DRD2—Parkinson's disease	1.64e-05	0.000115	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR7—Parkinson's disease	1.64e-05	0.000115	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—DRD2—Parkinson's disease	1.63e-05	0.000115	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—EDN1—Parkinson's disease	1.63e-05	0.000115	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—DRD2—Parkinson's disease	1.62e-05	0.000114	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR7—Parkinson's disease	1.62e-05	0.000114	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—DRD2—Parkinson's disease	1.59e-05	0.000112	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HTR7—Parkinson's disease	1.59e-05	0.000112	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.58e-05	0.000111	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	1.57e-05	0.000111	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	1.56e-05	0.00011	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—APOE—Parkinson's disease	1.56e-05	0.00011	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ADRBK1—Parkinson's disease	1.54e-05	0.000109	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—INSR—Parkinson's disease	1.52e-05	0.000107	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—INSR—Parkinson's disease	1.52e-05	0.000107	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR7—Parkinson's disease	1.49e-05	0.000105	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—DRD2—Parkinson's disease	1.49e-05	0.000105	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.49e-05	0.000105	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	1.47e-05	0.000104	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—FGB—Parkinson's disease	1.44e-05	0.000101	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HTR2A—Parkinson's disease	1.44e-05	0.000101	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—FGB—Parkinson's disease	1.43e-05	0.000101	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	1.43e-05	0.000101	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	1.43e-05	0.0001	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	1.42e-05	0.0001	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	1.42e-05	9.98e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—INS—Parkinson's disease	1.41e-05	9.94e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TAC1—Parkinson's disease	1.41e-05	9.93e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	1.4e-05	9.88e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD1—Parkinson's disease	1.38e-05	9.74e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	1.38e-05	9.69e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IGF2—Parkinson's disease	1.37e-05	9.65e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IGF2—Parkinson's disease	1.37e-05	9.64e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IGF2—Parkinson's disease	1.36e-05	9.58e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD3—Parkinson's disease	1.34e-05	9.43e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF2—Parkinson's disease	1.33e-05	9.38e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	1.33e-05	9.38e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—INS—Parkinson's disease	1.33e-05	9.38e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IGF1R—Parkinson's disease	1.33e-05	9.33e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IGF1R—Parkinson's disease	1.32e-05	9.32e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.32e-05	9.26e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IGF1R—Parkinson's disease	1.32e-05	9.26e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EDN1—Parkinson's disease	1.31e-05	9.22e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EDN1—Parkinson's disease	1.31e-05	9.21e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EDN1—Parkinson's disease	1.3e-05	9.15e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IGF1R—Parkinson's disease	1.29e-05	9.07e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EDN1—Parkinson's disease	1.27e-05	8.96e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	1.25e-05	8.81e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADRBK1—Parkinson's disease	1.25e-05	8.81e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	1.24e-05	8.76e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.24e-05	8.75e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.24e-05	8.71e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.22e-05	8.58e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—DRD2—Parkinson's disease	1.21e-05	8.53e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR7—Parkinson's disease	1.21e-05	8.53e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	1.21e-05	8.52e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	1.21e-05	8.48e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	1.21e-05	8.48e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NGF—Parkinson's disease	1.2e-05	8.48e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NGF—Parkinson's disease	1.2e-05	8.47e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	1.2e-05	8.42e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.19e-05	8.41e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NGF—Parkinson's disease	1.19e-05	8.41e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NGF—Parkinson's disease	1.17e-05	8.24e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	1.16e-05	8.15e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR2A—Parkinson's disease	1.15e-05	8.07e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HTR2A—Parkinson's disease	1.14e-05	8.06e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR2A—Parkinson's disease	1.14e-05	8.01e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HTR2A—Parkinson's disease	1.11e-05	7.84e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NGF—Parkinson's disease	1.1e-05	7.74e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	1.08e-05	7.61e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—APOE—Parkinson's disease	1.07e-05	7.5e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—APOE—Parkinson's disease	1.06e-05	7.49e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—APOE—Parkinson's disease	1.06e-05	7.44e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CASP3—Parkinson's disease	1.05e-05	7.4e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	1.05e-05	7.37e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	1.05e-05	7.37e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	1.05e-05	7.37e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL6—Parkinson's disease	1.04e-05	7.36e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—APOE—Parkinson's disease	1.04e-05	7.29e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF2—Parkinson's disease	1.02e-05	7.15e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	1.01e-05	7.11e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CASP3—Parkinson's disease	9.92e-06	6.98e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL6—Parkinson's disease	9.86e-06	6.94e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IGF1R—Parkinson's disease	9.81e-06	6.91e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	9.76e-06	6.87e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—APOE—Parkinson's disease	9.73e-06	6.85e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EDN1—Parkinson's disease	9.7e-06	6.83e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MAPK8—Parkinson's disease	9.67e-06	6.8e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	9.65e-06	6.79e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MAPK8—Parkinson's disease	9.12e-06	6.42e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—INS—Parkinson's disease	9.1e-06	6.41e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—INS—Parkinson's disease	9.09e-06	6.4e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—INS—Parkinson's disease	9.03e-06	6.36e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NGF—Parkinson's disease	8.91e-06	6.27e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NGF—Parkinson's disease	8.87e-06	6.24e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—INS—Parkinson's disease	8.84e-06	6.23e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	8.77e-06	6.17e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR2A—Parkinson's disease	8.48e-06	5.97e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	8.48e-06	5.97e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	8.44e-06	5.94e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	8.38e-06	5.9e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—INS—Parkinson's disease	8.31e-06	5.85e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—APOE—Parkinson's disease	7.89e-06	5.55e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—APOE—Parkinson's disease	7.85e-06	5.52e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NGF—Parkinson's disease	7.7e-06	5.42e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—APOE—Parkinson's disease	6.81e-06	4.8e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CASP3—Parkinson's disease	6.78e-06	4.77e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CASP3—Parkinson's disease	6.77e-06	4.77e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—INS—Parkinson's disease	6.74e-06	4.74e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—Parkinson's disease	6.73e-06	4.74e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—Parkinson's disease	6.73e-06	4.73e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	6.73e-06	4.73e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—INS—Parkinson's disease	6.7e-06	4.72e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	6.68e-06	4.7e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	6.59e-06	4.64e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	6.54e-06	4.61e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	6.23e-06	4.38e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	6.22e-06	4.38e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	6.19e-06	4.36e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	6.18e-06	4.35e-05	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—Parkinson's disease	6.17e-06	4.35e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	6.15e-06	4.33e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	6.05e-06	4.26e-05	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—Parkinson's disease	5.82e-06	4.1e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—INS—Parkinson's disease	5.82e-06	4.1e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	5.69e-06	4e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	5.02e-06	3.53e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	4.99e-06	3.51e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	4.98e-06	3.51e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	4.96e-06	3.49e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	4.61e-06	3.25e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	4.59e-06	3.23e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	4.33e-06	3.05e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	4.31e-06	3.03e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	3.98e-06	2.8e-05	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—Parkinson's disease	3.98e-06	2.8e-05	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—Parkinson's disease	3.97e-06	2.8e-05	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—Parkinson's disease	3.95e-06	2.78e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—Parkinson's disease	3.86e-06	2.72e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—Parkinson's disease	3.63e-06	2.56e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—Parkinson's disease	2.94e-06	2.07e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.93e-06	2.06e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—Parkinson's disease	2.54e-06	1.79e-05	CbGpPWpGaD
